Standard versus low-dose transdermal nitroglycerin: Differential effects on the development of tolerance and abnormalities of endothelial function

Journal of Cardiovascular Pharmacology

Volumn 56, Issue 4, 2010, Pages 354-359

  Uxa, Amar ^a   Thomas, George R ^a   Gori, Tommaso ^b   Parker, John D ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

applanation tonometry; dose; endothelial dysfunction; tolerance; transdermal nitroglycerin

Indexed keywords

GLYCERYL TRINITRATE; SALBUTAMOL;

AORTA PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; ENDOTHELIAL DYSFUNCTION; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; NORMAL HUMAN; PRIORITY JOURNAL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; TONOMETRY;

ADMINISTRATION, SUBLINGUAL; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; AEROSOLS; ALBUTEROL; CROSS-OVER STUDIES; DRUG TOLERANCE; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMANS; MALE; NITROGLYCERIN; TRANSDERMAL PATCH; VASODILATOR AGENTS;

EID: 77958469102     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181ed2dae     Document Type: Article

References (36)

1. Gori T, Parker JD. Nitrate tolerance: a unifying hypothesis. Circulation. 2002;106:2510-2513.
2. Gori T, Parker JD. The puzzle of nitrate tolerance: pieces smaller than we thought? Circulation. 2002;106:2404-2408.
3. Munzel T, Daiber A, Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res. 2005;97:618-628.
4. Needleman P, Land S, Johnson EMJ. Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther. 1972;181:489-497.
5. Glancy DL, Richter MA, Ellis EV, et al. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease. Am J Med. 1977;62:39-46.
6. Goldstein RE, Epstein SE. Nitrates in the prophylactic treatment of angina pectoris [Editorial]. Circulation. 1973;48:917-920.
7. Reichek N. Long-acting nitrates in the treatment of angina pectoris. JAMA. 1976;236:1399-1402.
8. Abrams J. Nitrates, package inserts, and the Food and Drug Administration. A clinical paradox. JAMA. 1981;246:1557-1558.
9. Munzel T, Sayegh H, Freeman BA, et al. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest. 1995;95: 187-194.
10. Hayward CS, Kraidly M, Webb CM, et al. Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol. 2002;40:521-528.
11. O'Rourke MF, Adji A. An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry. Curr Opin Cardiol. 2005;20:275-281.
12. Gallagher D, Adji A, O'Rourke MF. Validation of the transfer function technique for generating central from peripheral upper limb pressure waveform. Am J Hypertens. 2004;17:1059-1067.
13. O'Rourke MF, Takazawa K. Flawed measurement of brachial tonometry for calculating aortic pressure? Hypertension. 2009;54:e131; author reply e132.
14. Karamanoglu M, O'Rourke MF, Avolio AP, et al. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993;14:160-167.
15. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932-937.
16. Chen CH, Nevo E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95: 1827-1836.
17. Wilkinson IB, Hall IR, MacCallum H, et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002;22:147-152.
18. O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. Br J Clin Pharmacol. 2001;51:507-522.
19. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003;23: 554-566.
20. Soderstrom S, Nyberg G, O'Rourke MF, et al. Can a clinically useful aortic pressure wave be derived from a radial pressure wave? Br J Anaesth. 2002;88:481-488.
21. McEniery CM, Wallace S, Mackenzie IS, et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension. 2006;48:602-608.
22. Jiang XJ, O'Rourke MF, Jin WQ, et al. Quantification of glyceryl trinitrate effect through analysis of the synthesised ascending aortic pressure waveform. Heart. 2002;88:143-148.
23. Gori T, Floras JS, Parker JD. Effects of nitroglycerin treatment on baroreflex sensitivity and short-term heart rate variability in humans. J Am Coll Cardiol. 2002;40:2000-2005.
24. Vlachopoulos C, Hirata K, O'Rourke MF. Pressure-altering agents affect central aortic pressures more than is apparent from upper limb measurements in hypertensive patients: the role of arterial wave reflections. Hypertension. 2001;38:1456-1460.
25. Hashimoto J, Imai Y, O'Rourke MF. Monitoring of antihypertensive therapy for reduction in left ventricular mass. Am J Hypertens. 2007;20: 1229-1233.
26. Jeserich M, Munzel T, Pape L, Fischer C, et al. Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery disease. J Am Coll Cardiol. 1995;26:50-56.
27. Gori T, Harvey P, Floras JS, et al. Continuous therapy with nitroglycerin impairs endothelium-dependent vasodilation but does not cause tolerance in conductance arteries: a human in vivo study. J Cardiovasc Pharmacol. 2004;44:601-606.
28. Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA. 2002;99: 8306-8311.
29. Daiber A, Oelze M, Coldewey M, et al. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol. 2004;66:1372-1382.
30. Study SCTC. Acute and chronic antianginal efficacy of continuous twenty-four hour application of transdermal nitroglycerin. Am J Cardiol. 1992;68:1263-1273.
31. DeMots H, Glasser S. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 1989;13:786-788.
32. Chrysant SG, Glasser SP, Bittar N, et al. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol. 1993;72:1249-1256.
33. Parker JO, Amies MH, Hawkinson RW, et al. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group. Circulation. 1995; 91:1368-1374.
34. Stokes GS, Bune AJ, Huon N, et al. Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension. Hypertension. 2005;45:380-384.
35. Maple-Brown LJ, Piers LS, O'Rourke MF, et al. Central obesity is associated with reduced peripheral wave reflection in Indigenous Australians irrespective of diabetes status. J Hypertens. 2005;23: 1403-1407.
36. Weber T, Auer J, Lamm G, et al. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy\implications for risk stratification. J Card Fail. 2007;13:353-359.